l9n/ Mississippi

2025 Regular Session

House Bill 18

Prescription drugs; authorize to be imported into the State of Mississippi.

Did not become law. It stopped in the House of Representatives's Drug Policy Committee on February 4, 2025. The 2025 session has ended.

What it does

The synopsis the Legislature published with the bill.

AN ACT TO AUTHORIZE PRESCRIPTION DRUGS TO BE IMPORTED INTO THE STATE OF MISSISSIPPI FOR THE PURPOSE OF PROVIDING SAFE AND EFFECTIVE PRESCRIPTION DRUGS THAT HAVE THE HIGHEST POTENTIAL FOR COST SAVINGS TO THE STATE; TO DEFINE CERTAIN TERMS RELATING TO THE IMPORTATION AND EXPORTATION OF PRESCRIPTION DRUGS; TO AUTHORIZE AN ELIGIBLE IMPORTER TO IMPORT A PRESCRIPTION DRUG INTO THE STATE OF MISSISSIPPI FROM AN ELIGIBLE EXPORTER IF THE DRUG MEETS THE UNITED STATES FOOD AND DRUG ADMINISTRATION'S STANDARDS RELATED TO SAFETY, EFFECTIVENESS, MISBRANDING, AND ADULTERATION, AND IF IMPORTING THE DRUG WOULD NOT VIOLATE THE PATENT LAWS OF THE UNITED STATES; TO PROVIDE THAT AN ELIGIBLE EXPORTER IS EITHER AN INTERNATIONAL PRESCRIPTION DRUG WHOLESALE DISTRIBUTOR, A NONRESIDENT PRESCRIPTION DRUG MANUFACTURER, OR AN INTERNATIONAL EXPORT PHARMACY; TO PROVIDE THAT AN ELIGIBLE IMPORTER IS EITHER A WHOLESALE DISTRIBUTOR, A LICENSED PHARMACIST, OR A PHARMACY; AND FOR RELATED PURPOSES.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

Its course

January 10 to February 4, 2025, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action2 actions on 2 days

In the House of RepresentativesJan 10 to Feb 4 · stopped25 days

Drug PolicyJan 10 to Feb 4 · stopped25 days

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the House of Representatives Jan 10 – Feb 4

  1. Referred to the House committee on Drug Policy
  2. Died in committee in the House
All 2 actions, as published